← Back to headlines
Bristol-Myers Squibb's $14 Billion Neuroscience Drug Bet Disappoints
Bristol-Myers Squibb's significant $14 billion investment in a neuroscience drug has reportedly turned into an early letdown, indicating potential setbacks for the pharmaceutical giant's venture.
28 Apr, 09:00 — 28 Apr, 09:00
Sources
Showing 1 of 1 sources
Related Stories
Irish Health Agency Fined €645,000 for Storing Records in Derelict Sites
2h ago
New Urine Test Detects Over 90 Percent of Bladder Cancer Cases
2h ago
Swimmer Hospitalized Following Suspected Shark Attack in Massachusetts
6h ago
Wellington Clinics Suspends Kidney Transplants Amid Organ Harvesting Probe
12h ago